Onal, CemBozca, RecepDolek, YemlihaGuler, Ozan CemArslan, Gungor2021-06-302021-06-3020200033-8362http://hdl.handle.net/11727/6222Purpose To compare the incidental testicular doses during volumetric-modulated arc therapy (VMAT) in patients receiving prostate-only and pelvic lymphatic irradiation. Materials and methods Testicular doses in 40 intermediate- and high-risk prostate cancer patients were determined on treatment planning system (TPS) using the VMAT technique at 6 MV. Scattered testicular doses were also measured by MOSFET detectors placed on testis surface. The testicular doses of patients treated with prostate-only and pelvic field irradiation were compared. Results The median testicular doses measured per 200 cGy fraction by TPS and MOSFET detectors were 1.7 cGy (0.7-4.1 cGy) and 4.8 cGy (3.6-8.8 cGy), respectively. The TPS doses and MOSFET readings showed a significant strong correlation (Pearson r = 0.848, p < 0.001). The testicular doses measured by TPS (1.34 +/- 0.36 cGy vs. 2.60 +/- 0.95 cGy; p < 0.001) and MOSFET (4.52 +/- 0.64 cGy vs. 6.56 +/- 1.23 cGy; p < 0.001) were significantly lower in patients with prostate-only irradiation than in those with pelvic field irradiation. The mean cumulative scattered dose for prostate-only field delivering 78 Gy was 1.8 Gy and that for pelvic field irradiation was 2.6 Gy, consistent with the reported findings. Conclusions The patients with prostate-only irradiation received lower testicular doses than those with additional pelvic field irradiation possibly due to the increased scattered doses in large field irradiation using the VMAT technique. The clinical response to increased incidental testicular doses due to pelvic field irradiation remains unknown, and it warrants further investigation.enginfo:eu-repo/semantics/closedAccessProstate cancerRadiotherapyTesticular dosesDosimetryVolumetric-modulated arc therapyarticle12587777830005180495000022-s2.0-85081547257